Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Yousif A. Asiri"'
Autor:
Ahmed Ibrahim Fathelrahman, Majed Alrobaian, Waleed Mohammad Altowayan, Ibrahim Maghrabi, Yousif A. Asiri
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 6, Pp 649-654 (2022)
Basic expectation from graduates of any pharmacy program is to be able to provide pharmaceutical care at both patients and community levels, be able to solve problems arising during practice, be able to improve quality and outcomes of the services pr
Externí odkaz:
https://doaj.org/article/1a8943d7e9934b73915f4689294f14ed
Autor:
Maryam Ali Alharaibi, Abdullah A. Alhifany, Yousif A. Asiri, Monira M. Alwhaibi, Sheraz Ali, Parameaswari P. Jaganathan, Tariq M. Alhawassi
Publikováno v:
Annals of Saudi Medicine, Vol 41, Iss 3, Pp 147-156 (2021)
BACKGROUND: Multiple studies have investigated medication errors in hospitals in Saudi Arabia; however, prevalence data on prescribing errors and associated factors remains uncertain. OBJECTIVE: Assess the prevalence, type, severity, and factors asso
Externí odkaz:
https://doaj.org/article/ab02acdaeaa24338904bb7590b9bcbe1
Autor:
Walaa F. Alsanie, Sherin Abdelrahman, Majid Alhomrani, Ahmed Gaber, Hamza Habeeballah, Heba A. Alkhatabi, Raed I. Felimban, Charlotte A. E. Hauser, Hossam H. Tayeb, Abdulhakeem S. Alamri, Bassem M. Raafat, Sirajudheen Anwar, Khaled A. Alswat, Yusuf S. Althobaiti, Yousif A. Asiri
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Gabapentin is widely prescribed as an off-label drug for the treatment of various diseases, including drug and alcohol addiction. Approximately 83–95% of the usage of gabapentin is off-label, accounting for more than 90% of its sales in
Externí odkaz:
https://doaj.org/article/6e20f73c116b4315b2d20531ccfed413
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
Externí odkaz:
https://doaj.org/article/0be2159598fe4b8daa79c565dd1a572c
Autor:
Abdulhakim A. Alzahrani, Monira M. Alwhaibi, Yousif A. Asiri, Khalid M. Kamal, Tariq M. Alhawassi
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Prescribing errors (PEs) are a common cause of morbidity and mortality, both in community practice and in hospitals. Pharmacists have an essential role in minimizing and preventing PEs, thus, there is a need to document the nature
Externí odkaz:
https://doaj.org/article/3ed5e4f00d304d17b3fe5d1835a6535c
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
Data exploring parents' hesitancy to vaccinate their 5–11-year-old children against COVID-19, and associated factors, is limited. This study aims to investigate parents' beliefs and intentions to vaccinate their 5–11-year-old children using the H
Externí odkaz:
https://doaj.org/article/401061fdbde448b7b6b5974f09960642
Publikováno v:
Saudi Pharmaceutical Journal, Vol 28, Iss 4, Pp 397-402 (2020)
Objective: The objective of this study is to determine the level of attitude and perception of Saudi pharmacy students toward working in community pharmacies after graduation and to assess cultural, educational, and job related barriers and limitatio
Externí odkaz:
https://doaj.org/article/3033b37e16884901b835b31c97d85d64
Publikováno v:
Saudi Pharmaceutical Journal, Vol 28, Iss 4, Pp 381-386 (2020)
Foretinib, an oral multikinase inhibitor, is known to have anti-tumor effects against cancers. The doses and the levels of foretinib vary based on the type of cancer to be treated. An accurate and precise method is required to determine the level of
Externí odkaz:
https://doaj.org/article/f815802691824a6f9849d5a1573d5da2
Publikováno v:
Applied Sciences, Vol 12, Iss 17, p 8625 (2022)
Erdafitinib is an oral pan-fibroblast growth factor receptor (FGFR) inhibitor and has a potent antitumor activity against FGFR-aberrant malignancies. Erdafitinib has a narrow therapeutic index, and its pharmacokinetics are influenced by genetic varia
Externí odkaz:
https://doaj.org/article/85fa745158e94b98bc274b0559bc0b96
Autor:
Walaa F. Alsanie, Majid Alhomrani, Ahmed Gaber, Hamza Habeeballah, Heba A. Alkhatabi, Raed I. Felimban, Sherin Abdelrahman, Charlotte A. E. Hauser, Adeel G. Chaudhary, Abdulhakeem S. Alamri, Bassem M. Raafat, Abdulwahab Alamri, Sirajudheen Anwar, Khaled A. Alswat, Yusuf S. Althobaiti, Yousif A. Asiri
Publikováno v:
Cells, Vol 11, Iss 5, p 852 (2022)
Pregabalin is widely used as a treatment for multiple neurological disorders; however, it has been reported to have the potential for misuse. Due to a lack of safety studies in pregnancy, pregabalin is considered the last treatment option for various
Externí odkaz:
https://doaj.org/article/7fd0e3a0ad94482a83114eae6dacc38e